The pediatric clinical pharmacist in stem cell transplant and cellular therapy at the University of Minnesota Masonic Children’s Hospital and M Health Fairview offered an in-depth preview of the upcoming virtual meeting.
“I’ve been a pharmacist in transplant for over 15 years, [but] it’s still nice to go to the course because, even though it’s very nuts and bolts of transplant, the speakers are always updating their materials and bringing forward what is best practice at the time. Even what the course was 2 years ago, or 5 years ago, is not exactly the same [as what it will be in 2023].”
The American Society for Transplantation and Cellular Therapy (ASTCT) is kicking off a 2-day virtual course to provide essential education around the process of using hematopoietic stem cell transplantation (HSCT) in the clinical care of patients. The Fundamentals of HCT Training Course will feature a variety of speakers and experts who will seek to help attendees develop or enhance their skills in the treatment of patients undergoing these procedures. The live sessions will begin on Friday, April 28, 2023, at 8:00 AM ET.
To offer an overview of what attendees can expect from the case-based learning model meeting, CGTLive™ spoke with Susie Long, PharmD, a pediatric clinical pharmacist in stem cell transplant and cellular therapy at the University of Minnesota Masonic Children’s Hospital and M Health Fairview. Long, who also serves as chair-elect of the ASTCT Fundamentals of HCT Program Planning Committee, is giving a talk of her own on Day 1, titled, "Special Populations in Hematopoietic Cell Transplantation: Pediatrics." In this conversation with CGTLive, she summarized not only her talk, but explored in-depth the benefits of this meeting for the wide variety of clinicians who will be in attendance.
The target audience for the Fundamentals of HCT Training Course include new practitioners, residents, fellows, pharmacists, and nurses or those training in this discipline. Notably, each day of the course will feature a 30-minute roundtable discussion with all the day’s faculty. The meeting will offer attendees a maximum of 13.0 AMA PRA Category 1 Credit(s)™ or 13.0 contact hours (0.13 CEUs) of continuing pharmacy education credit for their participation in the live activity.
Bendamustine Is an Effective Alternative to Fludarabine-Based Lymphodepletion in LBCL
December 7th 2024In the wake of fludarabine shortages, lemphodepletion with bendamustine was found to be an effective alternative compared for patients with large B-cell lymphoma being treated with a CD19-directed CAR T-cell therapy.